Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria
· Delayed Price · Currency is BGN · Price in EUR 9.25
+0.75 (8.82%)
At close: Mar 6, 2026
BUL:THQM Revenue
In the year 2025, Tchaikapharma High Quality Medicines AD had annual revenue of 63.99M BGN with 20.42% growth. Tchaikapharma High Quality Medicines AD had revenue of 16.01M in the quarter ending December 31, 2025, with 25.80% growth.
Revenue
63.99M
Revenue Growth
+20.42%
P/S Ratio
26.77
Revenue / Employee
301.86K
Employees
212
Market Cap
1.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 63.99M | 10.85M | 20.42% |
| Dec 31, 2024 | 53.14M | 4.63M | 9.54% |
| Dec 31, 2023 | 48.51M | 5.37M | 12.44% |
| Dec 31, 2022 | 43.15M | 715.00K | 1.69% |
| Dec 31, 2021 | 42.43M | 2.33M | 5.80% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sopharma AD | 2.51B |
| Shelly Group SE | 292.87M |
| First Investment Bank AD | 417.80M |
| Speedy AD | 532.54M |
| Eurohold Bulgaria AD | 3.20B |
| Central Cooperative Bank AD | 279.57M |
| M+S Hydraulic AD | 152.96M |
| Velgraf Asset Management AD | 7.91M |